Avalon Global Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,500
Closed -$3.84M 58
2017
Q2
$4.01M Buy
16,500
+1,500
+10% +$352K 2.24% 17
2017
Q1
$3.58M Buy
+15,000
New +$3.49M 1.87% 29
2016
Q4
Sell
-20,060
Closed -$4.62M 47
2016
Q3
$4.62M Hold
20,060
2.76% 13
2016
Q2
$4.64M Buy
20,060
+5,000
+33% +$1.15M 2.68% 9
2016
Q1
$4.04M Hold
15,060
3.06% 12
2015
Q4
$4.71M Buy
+15,060
New +$4.48M 3.91% 6

Other funds holding AGN

Avalon Global Asset Management's AGN Position: Q3 2017 in Review

Avalon Global Asset Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 16,500 shares — an estimated $3.84M sold.

Avalon Global Asset Management first reported a position in AGN in Q4 2015 and held it in 6 quarters. The position peaked at $4.71M in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Avalon Global Asset Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Avalon Global Asset Management sold 16,500 Allergan plc shares in Q3 2017, an estimated $3.84M.
  • Avalon Global Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
  • Avalon Global Asset Management's Allergan plc position peaked at $4.71M in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Avalon Global Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.